← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Cigna grew through Evernorth, but cash flow and core margins moved the other way.
The read at a glance✓ Audited against SEC data
- Growth — +11.2% revenue to $274.90BOK
- Profitability — $9.20B operating income; net income +73.5%OK
- Cash quality — Operating cash flow -7.4%; earnings quality 100Watch
- Margins — Gross margin -436 bps; operating margin -46 bpsWatch
- Balance sheet — Long-term debt +6.7%; equity +1.7%Note
- Insiders — 1 open-market buy / 6 sellsNote
Business
The Cigna Group is a global health company built around two engines: Evernorth Health Services, which houses pharmacy benefit, specialty, care, and affordability capabilities, and Cigna Healthcare, which sells medical and coordinated health benefit solutions in the United States and internationally.
Where the revenue comes from
Fiscal 2025, as Cigna Group reports it. History and quarterly detail are in the app.
- Product$219.4B
- Short-duration$39.3B
- Health Care$35.6B
- Fees and other revenues$16.9B
- Long-duration$1.0B
Leadership changes
From Cigna Group's own filings, the day they're filed.
- David M. Cordani · CEO · appointmenteff. 2026-07-01
- Brian C. Evanko · Chief Executive Officer · appointmenteff. 2026-07-01
- Eric J. Foss · Director · appointmenteff. 2026-04-01
Latest filings
- 10-Q · Quarterly report2026-07-30
- 8-K · Company announcement2026-07-30
- 8-K · Company announcement2026-05-13
- 8-K · Company announcement2026-04-30
- 10-Q · Quarterly report2026-04-30
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Cigna Group, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.